| Primary Device ID | 06971922130066 |
| NIH Device Record Key | 3ed93374-5261-4b3b-957b-2d4346eb2ec9 |
| Commercial Distribution Status | In Commercial Distribution |
| Brand Name | LCD Visual Chart |
| Version Model Number | YPB-2100 |
| Company DUNS | 547954649 |
| Company Name | Chongqing Yeasn Science & Technology Co.,Ltd. |
| Device Count | 1 |
| DM Exempt | false |
| Pre-market Exempt | true |
| MRI Safety Status | Labeling does not contain MRI Safety Information |
| Human Cell/Tissue Product | false |
| Device Kit | false |
| Device Combination Product | false |
| Single Use | false |
| Lot Batch | false |
| Serial Number | false |
| Manufacturing Date | false |
| Expiration Date | false |
| Donation Id Number | false |
| Contains Natural Rubber Latex | false |
| Labeled No Natural Rubber Latex | false |
| RX Perscription | false |
| OTC Over-The-Counter | false |
| Device Issuing Agency | Device ID |
|---|---|
| GS1 | 06971922130066 [Primary] |
| HOX | Chart, Visual Acuity |
| Steralize Prior To Use | false |
| Device Is Sterile | false |
| Public Version Status | New |
| Device Record Status | Published |
| Public Version Number | 1 |
| Public Version Date | 2020-10-30 |
| Device Publish Date | 2020-10-22 |
| 06971922132558 - YEASN | 2024-12-09 This instrument is intended to be used for performing subjective refraction eye examinations. |
| 06971922132787 - YEASN | 2024-12-09 This instrument is intended to be used for performing subjective refraction eye examinations. |
| 06971922132794 - YEASN | 2024-12-09 This instrument is intended to be used for performing subjective refraction eye examinations. |
| 06971922136037 - YEASN | 2024-08-29 The eye refractometer measures the objective refractive errors (including spherical, cylindrical refractive errors, cylinder axi |
| 06971922131292 - YEASN | 2024-08-16 |
| 06971922132244 - YEASN | 2024-08-16 For checking the refractive state of human eye. |
| 06971922132763 - YEASN | 2024-08-16 This instrument is applicable with stand and projection for precision measurement of visual functions such as myopia, hyperopia, |
| 06971922133234 - YEASN | 2024-08-16 |